Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Singular Health Group's Cash Payments for the
six
months ended in Dec. 2025 was A$-3.36 Mil.
Singular Health Group's Cash Payments for the trailing twelve months (TTM) ended in Dec. 2025 was A$-5.15 Mil.
Singular Health Group Cash Payments Related Terms
Singular Health Group Cash Payments Historical Data
* Premium members only.
The historical data trend for Singular Health Group's Cash Payments can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Cash Payments represents cash flow paid from operating activities in the direct cash flow method.
Cash Payments for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-5.15 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Singular Health Group (ASX:SHG) has a Cash Payments of A$-5.15 Mil as of Dec. 2025. Cash Payments represents cash paid from operating activities in direct cash flow method. View historical data for Singular Health Group and its competitors.
Is Singular Health Group's Cash Payments too high?
Singular Health Group's current Cash Payments is A$-5.15 Mil. Overall, Singular Health Group has a GF Score™ of 24/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Singular Health Group's Cash Payments compare to VEEV and BTSG?
Singular Health Group's Cash Payments of A$-5.15 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Payments for a Healthcare Providers & Services company?
A good Cash Payments depends on the Healthcare Providers & Services industry context. However, Cash Payments should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Payments mean?
A high Cash Payments can signal that a stock is expensive relative to its fundamentals. Cash Payments represents cash paid from operating activities in direct cash flow method. View historical data for Singular Health Group and its competitors. Singular Health Group's current Cash Payments is A$-5.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singular Health Group stock overvalued right now?
Based on GuruFocus' analysis, Singular Health Group (ASX:SHG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.11, compared to a current price of A$0.20 — trading 81.8% above its estimated fair value. The current Cash Payments is A$-5.15 Mil. Singular Health Group's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Payments calculated?
Cash Payments is calculated from a company's financial statements. For Singular Health Group (ASX:SHG), the current Cash Payments is A$-5.15 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Singular Health Group (ASX:SHG) Overvalued in 2026?
Based on GuruFocus' analysis, Singular Health Group stock appears to be overvalued.
The current stock price of A$0.20 is trading 81.8% above its estimated GF Value™ of A$0.11.
GuruFocus considers Singular Health Group to be Significantly Overvalued.
Key valuation signals for ASX:SHG:
Cash Payments: A$-5.15 Mil
GF Value™: A$0.11 vs. price of A$0.20 (81.8% above fair value)
No single metric tells the full story. See the ASX:SHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Singular Health Group Ltd provides medical software solutions. The company's business segment is the provision of Volume Rendering Platform (VRP) software, providing 3D printing services and 3D machine sales. It operates in one segment, which is the provision and development of medical technology within Australia.
24GF Score
Get the complete analysis for ASX:SHG
Cash Payments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:SHG has been successfully added to your 
